Production (Stage)
ARYx Therapeutics, Inc.
ARYX
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Net Income | -2.52M | -3.64M | -6.39M | -5.79M | -8.15M |
| Total Depreciation and Amortization | 206.00K | 231.00K | 251.00K | 261.00K | 183.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 209.00K | 215.00K | 515.00K | 299.00K | 618.00K |
| Change in Net Operating Assets | -1.95M | -325.00K | -799.00K | -858.00K | 558.00K |
| Cash from Operations | -4.05M | -3.52M | -6.42M | -6.09M | -6.79M |
| Capital Expenditure | -8.00K | -- | -- | -44.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 281.00K | 204.00K | 370.00K | 7.31M | 3.09M |
| Cash from Investing | 273.00K | 204.00K | 370.00K | 7.27M | 3.08M |
| Total Debt Issued | 6.29M | -- | -- | -- | -- |
| Total Debt Repaid | -990.00K | -1.53M | -1.48M | -1.47M | -1.43M |
| Issuance of Common Stock | 22.00K | -- | 6.43M | 1.07M | 48.00K |
| Repurchase of Common Stock | -- | -55.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -219.00K | 0.00 |
| Cash from Financing | 5.32M | -1.58M | 4.94M | -616.00K | -1.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.55M | -4.89M | -1.11M | 564.00K | -5.09M |